James Rucker
Impact in
- Clinical Psychology top 0.5%
- Psychedelics and Drug Studies
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
Papers in
-
- Psychedelics and Drug Studies 50
- Pharmacology 42
- Cannabis and Cannabinoid Research 36
- Treatment of Major Depression 6
- Co-authors
- Camilla Day (3 shared papers)David Taylor (3 shared papers)David Erritzøe (4 shared papers)Michael Bloomfield (2 shared papers)Robin Carhart‐Harris (2 shared papers)Mark Bolstridge (2 shared papers)Amanda Feilding (2 shared papers)James A. Rickard (2 shared papers)
- Journals
- Journal of Psychopharmacology (11 papers)Expert Review of Neurotherapeutics (7 papers)Frontiers in Psychiatry (3 papers)Journal of Affective Disorders (3 papers)Brain and Behavior (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
James Rucker
104 papers receiving 3.9k citations
James Rucker's Hit Papers
Peers
Comparison fields: 5 of 134
- Clinical Psychology 2.9k
- Biological Psychiatry 238
- Cellular and Molecular Neuroscience 1.0k
- Organic Chemistry 1.3k
- Pharmacology 568
Countries citing papers authored by James Rucker
This map shows the geographic impact of James Rucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Rucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Rucker more than expected).
Fields of papers citing papers by James Rucker
This network shows the impact of papers produced by James Rucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Rucker. The network helps show where James Rucker may publish in the future.
Co-authors
The 25 scholars most cited alongside James Rucker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study Hit paper breakdown → | 2016 | 1088 |
| 2 | Psilocybin with psychological support for treatment-resistant depression: six-month follow-up Hit paper breakdown → | 2017 | 681 |
| 3 | 2017 | 240 | |
| 4 | 1997 | 202 | |
| 5 | Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review Hit paper breakdown → | 2022 | 164 |
| 6 | 2016 | 140 | |
| 7 | 2013 | 104 | |
| 8 | Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis Hit paper breakdown → | 2022 | 98 |
| 9 | 2021 | 74 | |
| 10 | 2014 | 61 | |
| 11 | 2022 | 59 | |
| 12 | 2022 | 59 | |
| 13 | 2021 | 50 | |
| 14 | 1998 | 46 | |
| 15 | 2021 | 44 | |
| 16 | 2021 | 44 | |
| 17 | 2011 | 41 | |
| 18 | 2022 | 41 | |
| 19 | 2023 | 41 | |
| 20 | 2021 | 39 |
About James Rucker
James Rucker is a scholar working on Clinical Psychology, Pharmacology, Organic Chemistry, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 118 papers that have together received 4.1k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (50 papers), Cannabis and Cannabinoid Research (36 papers), Chemical synthesis and alkaloids (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers), Treatment of Major Depression (6 papers), Diverse academic research themes (4 papers), Psychosomatic Disorders and Their Treatments (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Clinical Psychology (2.9k citations), Biological Psychiatry (238 citations), Cellular and Molecular Neuroscience (1.0k citations), Organic Chemistry (1.3k citations) and Pharmacology (568 citations). James Rucker has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Camilla Day, David Taylor, David Erritzøe, Michael Bloomfield, Robin Carhart‐Harris, Mark Bolstridge, Amanda Feilding, James A. Rickard, Mendel Kaelen and Allan H. Young. Their work appears in journals such as Journal of Psychopharmacology, Expert Review of Neurotherapeutics, Frontiers in Psychiatry, Journal of Affective Disorders and Brain and Behavior.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.